URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Keefer

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
AIDS Vaccines
44
1992
74
5.890
Why?
HIV-1
38
1992
593
3.550
Why?
HIV Infections
25
1993
616
2.100
Why?
HIV Envelope Protein gp120
22
1993
48
1.990
Why?
HIV Antibodies
24
1992
56
1.670
Why?
Genetic Vectors
9
1999
349
1.190
Why?
Vaccinia virus
9
1992
56
1.140
Why?
Vaccines, Synthetic
21
1991
88
1.120
Why?
Gene Products, env
9
1991
19
1.090
Why?
T-Lymphocytes, Cytotoxic
12
1996
147
0.850
Why?
Fowlpox virus
1
2011
2
0.790
Why?
Drug Carriers
1
2011
23
0.770
Why?
Double-Blind Method
27
1989
996
0.750
Why?
Protein Precursors
8
1991
84
0.740
Why?
Canarypox virus
4
2003
4
0.680
Why?
Immunization, Secondary
12
1992
72
0.660
Why?
CD8-Positive T-Lymphocytes
10
1997
229
0.650
Why?
Adult
44
1989
11572
0.610
Why?
Adjuvants, Immunologic
8
1993
118
0.600
Why?
Adolescent
25
1989
5044
0.550
Why?
Vaccination
8
1992
254
0.540
Why?
Immunization
6
1996
188
0.500
Why?
Middle Aged
35
1989
10013
0.450
Why?
Female
38
1991
20222
0.440
Why?
Pericarditis, Constrictive
1
2002
2
0.430
Why?
CD4-Positive T-Lymphocytes
9
1992
298
0.430
Why?
Immunocompetence
1
2002
30
0.420
Why?
Candida
1
2002
22
0.410
Why?
Peptide Fragments
9
1993
307
0.410
Why?
Neutralization Tests
15
1993
128
0.410
Why?
Candidiasis
1
2002
41
0.400
Why?
Avipoxvirus
4
1998
4
0.400
Why?
Male
35
1991
20139
0.400
Why?
Young Adult
9
2008
1084
0.400
Why?
Humans
55
1986
37165
0.400
Why?
Antibodies, Neutralizing
2
2010
34
0.380
Why?
HIV Seronegativity
8
1994
22
0.370
Why?
HIV Envelope Protein gp160
10
1991
17
0.350
Why?
Interferon-gamma
7
1993
341
0.350
Why?
Recombinant Proteins
11
1993
770
0.330
Why?
Immunity, Cellular
7
1991
135
0.300
Why?
Adenoviridae
4
2007
130
0.300
Why?
Squalene
1
1996
3
0.290
Why?
Polysorbates
1
1996
9
0.290
Why?
Vaccines, Subunit
4
2003
12
0.280
Why?
Herpesvirus 1, Human
2
2006
67
0.280
Why?
T-Lymphocytes
6
1993
564
0.270
Why?
Leukocytes, Mononuclear
3
1991
112
0.270
Why?
Epitopes
4
1986
208
0.260
Why?
Viral Vaccines
3
1991
105
0.260
Why?
Amino Acid Sequence
9
1993
1227
0.260
Why?
Dose-Response Relationship, Immunologic
6
1994
57
0.260
Why?
Human Immunodeficiency Virus Proteins
2
2010
2
0.250
Why?
Vaccines, DNA
2
2009
22
0.250
Why?
Time Factors
8
1989
3234
0.240
Why?
Lymphocyte Activation
10
1992
414
0.240
Why?
Enzyme-Linked Immunosorbent Assay
9
1993
472
0.240
Why?
Antibody Specificity
3
1986
108
0.230
Why?
Genes, gag
2
2006
7
0.220
Why?
DNA, Viral
3
1997
310
0.210
Why?
Antibodies, Anti-Idiotypic
1
2012
57
0.210
Why?
Autoantibodies
1
2012
109
0.200
Why?
Spectinomycin
1
1991
6
0.200
Why?
Urethritis
1
1991
11
0.200
Why?
Antigens, Viral
3
2004
144
0.200
Why?
Molecular Sequence Data
8
1993
2046
0.200
Why?
Chlamydia Infections
1
1991
21
0.200
Why?
Placebos
5
1989
185
0.190
Why?
Gene Products, gag
2
2006
23
0.190
Why?
Mannitol
1
2010
32
0.190
Why?
Oleic Acids
1
2010
16
0.190
Why?
Safety
7
1993
106
0.190
Why?
Antibodies, Viral
6
1992
456
0.190
Why?
Anti-Infective Agents
1
1991
78
0.190
Why?
Immune Evasion
1
2010
4
0.190
Why?
Adenoviridae Infections
1
2010
10
0.180
Why?
Abscess
1
2010
54
0.180
Why?
Follow-Up Studies
4
1994
1889
0.180
Why?
Simian immunodeficiency virus
1
2010
36
0.180
Why?
Models, Immunological
1
2010
62
0.180
Why?
CD4 Lymphocyte Count
4
1997
160
0.180
Why?
HIV-2
1
2009
4
0.180
Why?
Antifungal Agents
2
1997
60
0.170
Why?
Epitopes, T-Lymphocyte
1
2009
33
0.170
Why?
Acquired Immunodeficiency Syndrome
3
1992
201
0.170
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2008
84
0.160
Why?
Peptides
1
2010
293
0.160
Why?
National Institutes of Health (U.S.)
3
1994
64
0.160
Why?
Risk-Taking
3
1998
103
0.150
Why?
Cytokines
4
1998
575
0.150
Why?
Gene Expression Regulation, Viral
1
2006
37
0.150
Why?
Treatment Outcome
4
1997
2671
0.140
Why?
Viral Load
3
1997
141
0.140
Why?
Immunization Schedule
6
1996
62
0.130
Why?
Rabies Vaccines
1
2004
6
0.120
Why?
Staining and Labeling
1
2005
170
0.120
Why?
Viral Proteins
1
2005
214
0.120
Why?
Viral Envelope Proteins
1
2004
86
0.120
Why?
Promoter Regions, Genetic
1
2006
558
0.120
Why?
Clinical Trials, Phase II as Topic
2
1998
14
0.120
Why?
Data Interpretation, Statistical
1
2004
157
0.110
Why?
Hispanic Americans
1
2004
105
0.110
Why?
African Continental Ancestry Group
1
2004
125
0.110
Why?
Sex Characteristics
1
2004
141
0.110
Why?
Glycoproteins
1
2004
208
0.110
Why?
Pregnancy
3
1994
1941
0.110
Why?
Pericardiectomy
1
2002
1
0.110
Why?
HIV Antigens
2
1998
16
0.100
Why?
Rare Diseases
1
2002
28
0.100
Why?
env Gene Products, Human Immunodeficiency Virus
2
2011
18
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
1998
28
0.100
Why?
European Continental Ancestry Group
1
2004
238
0.100
Why?
Saponins
1
2001
6
0.100
Why?
Cells, Cultured
5
1993
2589
0.100
Why?
HIV Seropositivity
2
1994
36
0.090
Why?
T-Lymphocytes, Regulatory
1
2001
51
0.090
Why?
Combined Modality Therapy
1
2002
491
0.090
Why?
United States
3
1994
2847
0.090
Why?
Infectious Disease Transmission, Vertical
1
1999
48
0.090
Why?
Voluntary Workers
1
1998
7
0.090
Why?
AIDS Serodiagnosis
1
1998
10
0.090
Why?
Immunity, Active
2
1994
9
0.090
Why?
Pregnancy Complications, Infectious
1
1999
84
0.080
Why?
Prejudice
1
1998
52
0.080
Why?
Itraconazole
1
1997
5
0.080
Why?
Histoplasmosis
1
1997
9
0.080
Why?
Antibody Formation
3
1994
178
0.080
Why?
Th1 Cells
1
1998
70
0.080
Why?
Risk Assessment
1
2002
875
0.080
Why?
AIDS-Related Opportunistic Infections
1
1997
64
0.080
Why?
Th2 Cells
1
1998
91
0.080
Why?
Patient Participation
1
1997
74
0.070
Why?
Consumer Product Safety
1
1996
4
0.070
Why?
Immunotherapy
1
1997
88
0.070
Why?
Pregnancy Outcome
1
1997
131
0.070
Why?
Blotting, Western
3
1991
672
0.070
Why?
Mice, Inbred BALB C
2
2006
625
0.070
Why?
Flow Cytometry
2
2005
603
0.060
Why?
Influenza Vaccines
1
1998
269
0.060
Why?
Immunoenzyme Techniques
1
1994
214
0.060
Why?
Research
1
1994
185
0.060
Why?
Cytotoxicity, Immunologic
1
1993
119
0.060
Why?
Immunophenotyping
1
2012
126
0.050
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2011
2
0.050
Why?
nef Gene Products, Human Immunodeficiency Virus
1
2011
4
0.050
Why?
gag Gene Products, Human Immunodeficiency Virus
1
2011
8
0.050
Why?
Cross Reactions
2
1986
115
0.050
Why?
Cohort Studies
2
1994
984
0.050
Why?
Animals
6
1986
16416
0.050
Why?
Aluminum Hydroxide
2
2001
13
0.050
Why?
Immune Tolerance
1
2012
150
0.050
Why?
Injections, Intramuscular
1
1991
70
0.050
Why?
Drug Evaluation
1
1991
99
0.050
Why?
Anemia
1
2011
78
0.050
Why?
Freund's Adjuvant
1
2010
6
0.050
Why?
Hypersensitivity, Delayed
2
2000
52
0.050
Why?
Founder Effect
1
2010
6
0.050
Why?
Neoplasms
1
1997
743
0.050
Why?
Vaccines, Combined
2
1998
22
0.050
Why?
Simian Acquired Immunodeficiency Syndrome
1
2010
20
0.050
Why?
Prospective Studies
3
1997
1696
0.050
Why?
Macaca
1
2010
70
0.050
Why?
Amantadine
1
1989
21
0.040
Why?
RNA, Viral
2
1997
294
0.040
Why?
Immunoglobulin G
1
2011
494
0.040
Why?
Models, Theoretical
1
2010
194
0.040
Why?
Cell Division
1
1991
773
0.040
Why?
Sequence Alignment
1
2009
193
0.040
Why?
Genes, env
1
2007
8
0.040
Why?
B-Lymphocytes
1
2012
479
0.040
Why?
Chromium
1
2007
4
0.040
Why?
Acute Disease
1
2009
591
0.040
Why?
Mice
3
1986
6206
0.040
Why?
3T3 Cells
1
2006
75
0.040
Why?
Antibody Affinity
2
1994
13
0.040
Why?
Employment
2
1994
70
0.040
Why?
Factor V
1
1986
23
0.040
Why?
DNA Primers
1
2007
422
0.030
Why?
Aged
3
1993
7392
0.030
Why?
Megakaryocytes
1
1986
67
0.030
Why?
Plasmids
1
2007
361
0.030
Why?
Influenza, Human
1
1989
345
0.030
Why?
Dendritic Cells
1
2006
117
0.030
Why?
Lymphocytes
2
1993
298
0.030
Why?
Mucous Membrane
1
2004
46
0.030
Why?
Salmonella
1
2003
7
0.030
Why?
Clinical Trials, Phase I as Topic
1
2003
11
0.030
Why?
Time
1
2003
47
0.030
Why?
Leukocyte Count
2
1992
162
0.030
Why?
Base Sequence
1
2007
1721
0.030
Why?
Transcription, Genetic
1
2006
824
0.030
Why?
Cell Line
1
2006
1623
0.030
Why?
Immunity, Mucosal
1
2001
22
0.030
Why?
Microspheres
1
2001
56
0.020
Why?
Vaccines, Attenuated
1
2001
86
0.020
Why?
HIV Protease
1
2001
22
0.020
Why?
Antibody-Producing Cells
1
2001
32
0.020
Why?
Clinical Trials as Topic
1
2005
685
0.020
Why?
Randomized Controlled Trials as Topic
1
2003
415
0.020
Why?
CHO Cells
1
2001
191
0.020
Why?
Administration, Oral
1
2001
314
0.020
Why?
Retroviridae Proteins
1
1999
11
0.020
Why?
Cricetinae
1
2001
393
0.020
Why?
Genes, Viral
1
1999
86
0.020
Why?
False Positive Reactions
1
1998
88
0.020
Why?
Dose-Response Relationship, Drug
2
1989
1142
0.020
Why?
Rabies virus
1
1998
4
0.020
Why?
Virus Replication
2
1989
307
0.020
Why?
Cytotoxicity Tests, Immunologic
1
1998
30
0.020
Why?
Sequence Analysis
1
1998
27
0.020
Why?
Antibodies, Blocking
1
1998
11
0.020
Why?
Substance Abuse, Intravenous
1
1998
18
0.020
Why?
Histoplasma
1
1997
2
0.020
Why?
Antigens, CD4
1
1998
39
0.020
Why?
Polysaccharides
1
1997
41
0.020
Why?
Culture Media
1
1998
196
0.020
Why?
Antigens, Fungal
1
1997
35
0.020
Why?
Proviruses
1
1997
11
0.020
Why?
Insurance, Health
1
1998
145
0.020
Why?
Lymphocyte Count
1
1997
56
0.020
Why?
Virus Cultivation
1
1996
29
0.020
Why?
Recurrence
1
1997
697
0.020
Why?
Incidence
1
1998
682
0.020
Why?
Survival Analysis
1
1997
589
0.020
Why?
Longitudinal Studies
1
1997
413
0.020
Why?
Reference Values
1
1996
453
0.020
Why?
Insurance, Life
1
1994
2
0.020
Why?
Phenotype
1
1998
756
0.020
Why?
Polymerase Chain Reaction
1
1997
597
0.020
Why?
Infant, Newborn
1
1999
1836
0.020
Why?
Antibodies, Antinuclear
1
1993
31
0.020
Why?
Risk Factors
1
2001
2331
0.010
Why?
Glycosylation
1
1993
63
0.010
Why?
Vero Cells
1
1993
56
0.010
Why?
Antigens, CD8
1
1993
30
0.010
Why?
HIV Envelope Protein gp41
1
1993
4
0.010
Why?
Questionnaires
1
1998
1061
0.010
Why?
Liver
1
1997
884
0.010
Why?
Binding, Competitive
1
1993
210
0.010
Why?
Random Allocation
1
1989
253
0.010
Why?
Retrospective Studies
1
1994
2302
0.010
Why?
Influenza A virus
1
1989
218
0.010
Why?
Histocytochemistry
1
1986
129
0.010
Why?
Molecular Weight
1
1986
372
0.010
Why?
Microscopy, Fluorescence
1
1986
277
0.010
Why?
Antibodies, Monoclonal
1
1986
748
0.010
Why?

Visualizations


Keefer's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department